Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis – a propensity score-matched intention-to-treat analysis
Author:
Funder
Mary och Georg C. Ehrnrooths Stiftelse
Novartis Pharmaceuticals Corporation
Academy of Finland
Helsingin ja Uudenmaan Sairaanhoitopiiri
Sigrid Juséliuksen Säätiö
Astellas Pharma US
Medicinska Understödsföreningen Liv och Hälsa
Publisher
Elsevier BV
Subject
Hepatology
Reference27 articles.
1. Primary sclerosing cholangitis-a comprehensive review;Karlsen;J Hepatol,2017
2. Electronic address: easloffice@easloffice.eu, European association for the study of the liver. EASL clinical practice guidelines on sclerosing cholangitis;J Hepatol,2022
3. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis;Weismüller;Gastroenterology,2017
4. Characteristics, trends, and outcomes of liver transplantation for primary sclerosing cholangitis in female versus male patients: an analysis from the European liver transplant registry;Berenguer;Transplantation,2021
5. Timing, management, and outcomes of liver transplantation in primary sclerosing cholangitis;Martin;Semin Liver Dis,2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3